+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI In Vitro Diagnostic Market - Global Forecast 2025-2030- Product Image
AI In Vitro Diagnostic Market - Global Forecast 2025-2030- Product Image
Sale

AI In Vitro Diagnostic Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141842
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence is redefining the in vitro diagnostics (IVD) market, enabling organizations to drive operational efficiency, accuracy, and adaptability amid ongoing industry changes. Leadership teams navigating this dynamic landscape require actionable insight to optimize resource allocation, ensure compliance, and position their businesses for sustained competitive advantage.

Market Snapshot: AI-Enabled In Vitro Diagnostics

The AI-powered in vitro diagnostics market is experiencing significant growth, shaped by advancements in machine learning, deep learning, computer vision, and natural language processing. Demand for high-throughput laboratory workflows and precision-driven clinical results is compelling diagnostic developers and healthcare providers alike to integrate intelligent automation across the value chain. Growing adoption of cloud-native solutions and evolving regulatory pathways further facilitate the rapid implementation of next-generation diagnostic systems. As the convergence of digital pathology, genomics, and bioinformatics accelerates, stakeholders are seeking to realign strategies, with a strong focus on algorithmic transparency, robust validation, and efficient deployment models.

Scope & Segmentation of the AI In Vitro Diagnostics Market

  • Test Types: Flow cytometry, immunoassay, microarray, next generation sequencing (exome sequencing, targeted panel, transcriptome sequencing, whole genome sequencing), PCR.
  • Applications: Autoimmune, cardiology, genetic testing, infectious disease (bacterial infection, parasitic infection, viral infection), oncology.
  • Technologies: Computer vision, deep learning, machine learning (reinforcement learning, supervised learning, unsupervised learning), natural language processing.
  • End Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, research institutes.
  • Components: Hardware, services (consulting, integration, support), software.
  • Deployment Modes: Cloud based, hybrid, on premise.
  • Key Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).

Key Takeaways for Senior Decision-Makers

  • AI is transforming diagnostic workflows, moving from manual interpretation techniques to data-driven models that enhance clinical confidence and speed up time-to-result cycles.
  • Integration of digital pathology and comprehensive bioinformatics requires organizations to re-evaluate their technology stacks and ensure modular, interoperable infrastructure for future-proof flexibility.
  • Regulatory agencies are updating frameworks to support AI-based diagnostic approvals, prioritizing transparent validation processes and robust performance standards.
  • Regional market dynamics, including private investment climates and regulatory harmonization efforts, influence adoption rates and go-to-market requirements across different geographies.
  • Enhanced supply chain resiliency, through nearshoring and domestic manufacturing partnerships, is becoming critical in response to international trade disruptions and tariff implementations.
  • Successful market players use both in-house innovation and targeted acquisitions, while building cross-sector partnerships to maximize data orchestration and clinical integration capabilities.

Tariff Impact on the U.S. Value Chain

The 2025 tariffs are affecting the United States IVD market by increasing import duties on critical components such as specialized reagents, microfluidic devices, and semiconductor chips for AI accelerators. Diagnostic companies are responding by strengthening ties with domestic contract manufacturers, expanding in-house reagent production, and exploring vertical integration to offset cost pressures and ensure supply chain stability.

Methodology & Data Sources

This research utilizes a comprehensive methodology, combining rigorous secondary analysis of peer-reviewed publications, regulatory releases, clinical trial registries, and patent filings. Primary interviews with laboratory directors, software developers, and regulatory experts supplement the data, while proprietary analytics and triangulation ensure well-grounded segmentation and actionable findings.

Why This Report Matters

  • Delivers segmented insights on test types, applications, technologies, and regional opportunities for strategic planning.
  • Identifies regulatory and operational factors influencing successful AI integration for IVD developers, investors, and healthcare leaders.
  • Supports decision-makers in mitigating risks and capitalizing on evolving tariff and supply chain scenarios.

Conclusion

Organizations able to combine robust data governance, adaptable technology architectures, and resilient operations are best positioned to capture value as artificial intelligence accelerates innovation in in vitro diagnostics. Strategic collaboration, operational agility, and rigorous validation remain crucial for market leadership in this evolving sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory evolution for AI driven in vitro diagnostic devices under emerging global standards
5.2. Integration of multiomic data and machine learning algorithms in in vitro diagnostic assay development
5.3. Adoption of edge computing and embedded AI for rapid point of care in vitro diagnostic testing
5.4. Implementation of explainable AI models to enhance clinical trust in in vitro diagnostic workflows
5.5. Strategic partnerships between AI startups and established in vitro diagnostic manufacturers for scalability
5.6. Data governance and privacy frameworks for protecting patient information in AI driven diagnostic pipelines
5.7. Utilization of digital pathology imaging combined with AI for improved biomarker detection accuracy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI In Vitro Diagnostic Market, by Test Type
8.1. Introduction
8.2. Flow Cytometry
8.3. Immunoassay
8.4. Microarray
8.5. Next Generation Sequencing
8.5.1. Exome Sequencing
8.5.2. Targeted Panel
8.5.3. Transcriptome Sequencing
8.5.4. Whole Genome Sequencing
8.6. PCR
9. AI In Vitro Diagnostic Market, by Application
9.1. Introduction
9.2. Autoimmune
9.3. Cardiology
9.4. Genetic Testing
9.5. Infectious Disease
9.5.1. Bacterial Infection
9.5.2. Parasitic Infection
9.5.3. Viral Infection
9.6. Oncology
10. AI In Vitro Diagnostic Market, by Technology
10.1. Introduction
10.2. Computer Vision
10.3. Deep Learning
10.4. Machine Learning
10.4.1. Reinforcement Learning
10.4.2. Supervised Learning
10.4.3. Unsupervised Learning
10.5. Natural Language Processing
11. AI In Vitro Diagnostic Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals And Clinics
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. AI In Vitro Diagnostic Market, by Component
12.1. Introduction
12.2. Hardware
12.3. Services
12.3.1. Consulting
12.3.2. Integration
12.3.3. Support
12.4. Software
13. AI In Vitro Diagnostic Market, by Deployment Mode
13.1. Introduction
13.2. Cloud Based
13.3. Hybrid
13.4. On Premise
14. Americas AI In Vitro Diagnostic Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa AI In Vitro Diagnostic Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific AI In Vitro Diagnostic Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche AG
17.3.2. Abbott Laboratories
17.3.3. Siemens Healthineers AG
17.3.4. Thermo Fisher Scientific Inc.
17.3.5. Danaher Corporation
17.3.6. bioMérieux SA
17.3.7. Sysmex Corporation
17.3.8. QIAGEN N.V.
17.3.9. Ortho Clinical Diagnostics, Inc.
17.3.10. Hologic, Inc.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. AI IN VITRO DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AI IN VITRO DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AI IN VITRO DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AI IN VITRO DIAGNOSTIC MARKET: RESEARCHAI
FIGURE 28. AI IN VITRO DIAGNOSTIC MARKET: RESEARCHSTATISTICS
FIGURE 29. AI IN VITRO DIAGNOSTIC MARKET: RESEARCHCONTACTS
FIGURE 30. AI IN VITRO DIAGNOSTIC MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI IN VITRO DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TARGETED PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TARGETED PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES AI IN VITRO DIAGNOSTIC MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 150. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 151. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 154. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 155. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 158. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 159. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 162. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 163. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 164. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 165. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 166. CANADA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 170. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 171. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 178. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 179. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 182. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 183. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 184. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 185. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 280. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 281. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 290. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 291. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 292. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 293. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 300. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 301. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 304. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 305. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 306. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 307. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE AI IN VITRO DIAGNOSTIC MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA AI IN VITRO DIAGNOSTIC MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI In Vitro Diagnostic Market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMérieux SA
  • Sysmex Corporation
  • QIAGEN N.V.
  • Ortho Clinical Diagnostics, Inc.
  • Hologic, Inc.

Related Topics

Related Reports

In Vitro Diagnostic Products Market - Global Forecast 2025-2030 - Product Image

In Vitro Diagnostic Products Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
In-Vitro Diagnostics Quality Control Market - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Quality Control Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030 - Product Image

In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030

  • Report
  • 740 Pages
  • Global
From
Clinical Chemistry and Immunoassay Industry, Global, 2023-2028 - Product Image

Clinical Chemistry and Immunoassay Industry, Global, 2023-2028

  • Report
  • Global
From
Immunoassay Interference Blocker - Global Strategic Business Report - Product Image

Immunoassay Interference Blocker - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.